Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC 1-propanesulfonamide derivative (PROTAC BRAF-V600E degrader-1) | 2417296-84-3 | 98.0% | C48H54F2N10O10S | 10MG
SDP

Catalog No. 5000259384
Encompass_Preferred

PROTAC BRAF-V600E degrader-1 is a research-grade targeted protein degrader that selectively induces proteasomal degradation of the oncogenic BRAF-V600E mutant. It shows low-nanomolar affinity for BRAF variants and is intended for cellular and biochemical research applications.

  • Selective degradation of BRAF-V600E via the ubiquitin-proteasome system.
  • Low-nanomolar binding affinity to BRAF and BRAF-V600E for potent activity.
  • High purity suitable for cellular assays and biochemical studies.
  • Available in small-mass sizes convenient for research workflows.
  • Provided for research use only; not for clinical applications.

Catalog No. 50-002-59384 Supplier Medchemexpress LLC Supplier No. HY13748710MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

PROTAC BRAF-V600E degrader-1 is a research-grade targeted protein degrader that selectively induces proteasomal degradation of the oncogenic BRAF-V600E mutant. It shows low-nanomolar affinity for BRAF variants and is intended for cellular and biochemical research applications.

  • Selective degradation of BRAF-V600E via the ubiquitin-proteasome system.
  • Low-nanomolar binding affinity to BRAF and BRAF-V600E for potent activity.
  • High purity suitable for cellular assays and biochemical studies.
  • Available in small-mass sizes convenient for research workflows.
  • Provided for research use only; not for clinical applications.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.